pathogen safety

How do you find out the industry opinion on a topic? Simply, speak with them. Senior Conference Producer John Shah has spoken with hundreds of professionals working in pathogen safety from industry...

In 2008 and 2009, Genzyme sites were affected by vesivirus infection. This shut down two sites for decontamination. In this candid interview, Lada Laenen, Managing Principal Scientist, Hea...

As life sciences organizations outsource more of their non-core activities, the safety systems associated with those functions become increasingly complex. Managing safety requires a set of capabili...

Following the success of last year’s crisis management session, this year’s meeting again enables you to calmly pool, apply and receive feedback on what to do when contamination is reported. [inl...

Jürgen Blusch, Head of Cell Substrate Analytics at Novartis speaks to Pharma IQ on the topics of mitigating risk in pathogen safety, new technologies and techniques such as nucleic acid based t...

The story of the fungal meningitis outbreak caused by unsuitable manufacturing conditions at the New England COmpounding Centre was hard to follow. Now, almost a year on the Centres for Disease...

As pathogens continue to adapt and develop so must your strategy to prevent contamination. With both the financial cost and the damage to reputation so high is it critical to keep at the cutting edg...

Implementing effective pathogen safety strategies is essential for preventing contamination and ensuring the safety of your biologics. Raw materials can bring a pathogen or virus into your manufacturi...

Gerald Clarke:          Hello, everyone, and welcome to this Pharma IQ podcast. I’m Gerald Clarke, Editor at Pharma IQ. Today I’m joined by L...